Women experience most important changes in menopause metabolism. Weight gain starts during perimenopause and continues at approximately 1.5 pounds each year through their 50s. The connection between menopause and weight gain matters because visceral belly fat in postmenopausal women accounts for 15% to 20% of total body weight, compared with just 5% to 8% in premenopausal women. This fundamental change in menopause and metabolism creates health risks like increased cardiovascular disease and type 2 diabetes. This piece explores how menopause affects metabolism, why menopause slows metabolism, and evidence-based strategies to manage menopause weight gain.
The Hormonal Shifts That Change Your Metabolism After 55
The sequence from perimenopause to postmenopause
The hormonal transition begins long before the final menstrual period. Perimenopause starts eight to 10 years before menopause, usually when women reach their 40s [1]. One of the earliest changes involves inhibin, a hormone the ovaries produce that regulates follicle-stimulating hormone (FSH). FSH levels rise in response as inhibin levels decline [1].
These FSH fluctuations create dramatic swings in oestrogen production. The ovaries produce more oestrogen when FSH levels spike. Oestrogen levels fall when FSH drops [1]. This pattern continues for months to years and creates the unpredictable symptoms characteristic of perimenopause. Menopause occurs at an average age of 51 in the United States [2] and marks 12 consecutive months without menstruation.
Postmenopause follows menopause and continues for the remainder of a woman's life. The ovaries produce very little oestrogen in this phase and leave women in a permanent state of oestrogen deficiency [3]. Life expectancy in developed countries means many women spend half their lives postmenopausal. Understanding how these hormonal changes affect metabolic health after 55 becomes critical.
How oestradiol loss disrupts metabolic rate
Oestradiol, the primary form of oestrogen, regulates resting metabolic rate through multiple mechanisms. Research suppressing ovarian function in premenopausal women demonstrates that resting metabolic rate drops by the equivalent of 50 to 70 calories per day when oestrogen declines [4]. Women who received oestrogen rather than placebo did not experience this metabolic slowdown [4].
This seemingly modest decrease creates substantial weight gain over time. This metabolic drop produces about one pound of fat mass every two to three months without reducing food intake or increasing exercise [4]. The cumulative effect becomes significant during the years-long transition through perimenopause and into postmenopause.
Oestradiol influences metabolism through oestrogen receptor alpha (ERα), which is expressed abundantly in the hypothalamus [4]. This brain region coordinates food consumption, body weight homeostasis and energy expenditure [5]. Global disruption of ERα in mice guides to hyperphagia, increased adiposity, reduced metabolism and insulin resistance [4]. The protective effect of oestrogen on oxidative stress is arbitrated through mitochondrial function, where more than 90% of cellular ATP is generated [5].
The hormone also affects spontaneous physical activity. Studies removing ovaries from female animals show spontaneous physical activity decreases by 50 to 70 percent within one week [4]. Animals receiving oestrogen replacement return to their previous activity levels and demonstrate oestrogen's role in regulating energy balance beyond direct metabolic effects.
Why progesterone and testosterone matter too
Oestrogen dominates menopause discussions, but progesterone and testosterone contribute to metabolic changes. Progesterone treatment in postmenopausal women increased muscle protein fractional synthesis rate by about 50% [6]. This hormonal influence on muscle protein turnover affects metabolic rate, since muscle tissue burns more calories than fat tissue.
Testosterone levels in women decrease by around 50% between age 20 and age 60 [6]. This decline accelerates following surgical menopause due to ovarian removal [6]. Testosterone contributes to energy levels, mood, cognitive function and physical wellbeing beyond sexual function [6]. The drop in testosterone, coupled with other hormonal changes, contributes to fatigue, low mood, anxiety, brain fog, muscle loss and bone loss [7].
Research dissecting 510 women treated with transdermal testosterone for four months found significant improvements across 10 symptoms, with 'loss of interest in most things' improving in 56% of women and 'crying spells' in 55% [8]. These cognitive and mood symptoms affect motivation for physical activity and dietary adherence and indirectly influence menopause metabolism.
The perfect storm effect of multiple hormone decline
The simultaneous decline of oestradiol, progesterone and testosterone creates compounding metabolic challenges. Menopausal women face three times the likelihood of developing obesity and metabolic syndrome compared with premenopausal women [5]. This risk reflects the combined effects of reduced metabolic rate, altered fat distribution, decreased muscle protein synthesis and lower spontaneous activity.
The testosterone-to-oestrogen ratio changes during menopause, as testosterone levels change little during early menopause while oestrogen drops [2]. This altered ratio may provide a better predictor of cardiovascular disease risk than either hormone alone [9]. Studies indicate that increased androgenicity in peri- and postmenopausal women associates with an unfavourable cardiovascular risk profile [9].
These hormonal changes meet and affect body composition. Women lose about one kilogramme of lean mass over five to six months of suppressed ovarian function [4]. CT scans reveal muscle size shrinking in response to declining ovarian hormones, a process that oestrogen replacement prevents [4]. This muscle loss compounds metabolic slowdown and creates a cycle that accelerates inflammation and menopause complications.
Understanding how NAD supports weight loss and fat metabolism becomes relevant during this multi-hormone decline, as energy production at the cellular level faces disruption from multiple pathways simultaneously.
How Menopause Slows Your Metabolic Rate
Oestrogen's direct effect on mitochondrial function
Oestrogen acts directly on the mitochondrial respiratory chain through oestrogen receptors at the molecular level. This enhances the assembly efficiency of complexes and improves ATP synthesis capacity [9]. Mitochondria generate more than 90% of cellular ATP. This oestrogen-mediated function is central to energy production throughout the body.
Oestrogen regulates mitochondrial function by modulating expression of nuclear-encoded mitochondrial proteins and activating cytoplasmic signalling pathways [9]. The hormone also activates mitochondrial biogenesis and provides antioxidant effects. These effects inhibit the accumulation of reactive oxygen species (ROS) by a lot and protect the stability of mitochondrial membrane potential [9].
Mitochondrial dysfunction accelerates once oestrogen levels decrease during menopause. Studies show that ovariectomised mice exhibit decreased mitochondrial respiratory function, cellular redox state, and insulin sensitivity in skeletal muscle [9]. Oestrogen deficiency reduces SIRT3-mediated Superoxide Dismutase 2 (SOD2) deacetylation. This weakens the ROS scavenging ability [9].
The loss of oestrogen also inhibits autophagic flux. Damaged mitochondria accumulate and form a vicious cycle of ROS-mitochondrial damage [9]. This cellular-level dysfunction translates directly into reduced whole-body energy expenditure and metabolic slowdown.
Why you gain weight eating the same amount
Postmenopausal women consume less energy to maintain simple life processes due to decreased systemic oxygen consumption and energy expenditure [9]. Research demonstrates that ovariectomised mice show reduced systemic O2 consumption and energy expenditure. Weight gain associated with increased body fat follows [9].
The decline affects both resting metabolic rate (RMR) and total energy expenditure (TEE). Studies comparing pre- and postmenopausal women found postmenopausal women had lower RMR and TEE. They spent much less time doing moderate exercise [9]. Postmenopausal women also demonstrate lower fat oxidation and energy expenditure during exercise than premenopausal women. This reduces the capacity for substrate utilisation by skeletal muscle [9].
Both free energy expenditure and sleeping energy expenditure decline over time in mid-life women. The decrease in sleeping energy expenditure was 1.5 times greater in women who became postmenopausal over a four-year follow-up period [9]. Both RMR and activity energy expenditure (AEE) reduce without an equivalent reduction in energy intake. An increase in BMI along with increased health risks becomes inevitable [9].
The theoretical weight gain reaches 8.8 kg per year without compensatory dietary changes [9]. This projection illustrates why maintaining the same eating patterns during menopause produces rapid fat accumulation.
Measuring the metabolic rate drop in studies
Specific measurements reveal the magnitude of metabolic decline. Postmenopausal women showed a lower RMR value of 493 kJ by a lot, coupled with a lower TEE of 1819 kJ compared with premenopausal women [9]. These differences translate to measurable daily caloric deficits in energy burning.
Activity counts were lower in postmenopausal women compared with premenopausal women [9]. Postmenopausal women had a lower TEE, with a tendency for lower AEE [9]. The proportion of the day spent performing moderate-intensity exercise differed between groups [9].
Research on postmenopausal women reveals worse blood sugar markers. These include fasting glucose, insulin, and HbA1c, along with greater insulin insensitivity [9]. These metabolic changes occur independent of age. Menopause itself drives the metabolic disruption rather than ageing alone [9].
The muscle loss factor that makes it worse
Sarcopenia refers to degenerative loss of skeletal muscle that occurs at a rate of 3-8% every 10 years after age 30. The rate accelerates with age [9]. Women develop sarcopenia earlier than men. The decline of skeletal muscle mass and strength accelerates at menopause onset [9].
Lower lean mass in postmenopausal women associates with lower RMR [9]. Body composition analyses reveal increased adiposity and decreased lean body mass. This creates an unfavourable shift that contributes to reduced basal metabolic rate and decreased capacity for energy expenditure [9].
Muscle tissue burns more calories than fat tissue. The loss of muscle mass slows the rate at which the body uses calories [10]. This process makes maintaining a healthy weight more difficult. Sarcopenia coexisting with osteoporosis results in osteosarcopenia. This increases the risk of weakness, hospitalisation, and death [9].
Body function impairment originates from muscle loss in menopausal women. This leads to difficulties carrying out voluntary activities and reduces quality of life [9]. This muscle-based metabolic decline compounds the direct mitochondrial effects of oestrogen loss. Multiple pathways exist through which menopause metabolism deteriorates.
Why Belly Fat Increases After Menopause
The move from hips and thighs to abdomen
Fat storage patterns change as women transition through menopause. The proportion of fat to body weight increases more in women than in men, whilst fat storage moves from the hips and thighs to the upper body and abdomen [11]. This transformation represents a move from a gynoid fat distribution pattern to an android pattern and alters body composition [12].
Postmenopausal women store substantially more visceral adipose tissue (VAT) than premenopausal women for a given total fat mass [9]. Research measuring body composition found postmenopausal women had 123% more VAT mass compared with premenopausal women [9]. Postmenopausal women stored 18% more VAT for the same amount of total body fat [9].
The waistline can expand by inches as visceral fat pushes out against the abdominal wall, even if weight remains stable or within a healthy range [11]. Many women notice increased menopause belly fat despite not gaining overall weight [9]. This redistribution occurs because oestradiol regulates fat distribution, and as levels fluctuate and reduce during perimenopause, fat moves to the abdomen [9].
How oestrogen prevents visceral fat
Oestradiol directs fat storage to specific body regions before menopause. The hormone distributes fat mostly to the breasts, bottom and thighs and creates the characteristic female body shape [9]. Higher oestrogen levels increase subcutaneous white adipose tissue expansion whilst blunting visceral white adipose tissue growth [12].
Subcutaneous fat sits just below the skin, whereas visceral fat represents a deeper, internal fat that surrounds vital organs [9]. The mechanisms behind fat redistribution towards increased VAT deposition with menopause remain partially understood. Increased expression of inflammatory markers, immune cell infiltration and hypoxia in subcutaneous adipose tissue all associate with increased VAT deposition, even after correcting for total fat mass [9].
The manner in which adipose tissue expands and remodels affects the risk of metabolic disease [9]. Testosterone becomes more available as oestrogen levels drop and triggers a redistribution of body fat, often causing accumulation in the abdominal region [9]. Subcutaneous adipose tissue dysfunction causes lipid spillover, whereby lipids redirect and store in less favourable anatomic locations such as the VAT and other ectopic sites [9].
Why visceral fat creates metabolic problems
Visceral fat produces much more serious health consequences than subcutaneous fat. The distribution of body fat modulates obesity-related risk for cardiometabolic disease, with individuals who store body fat within the abdominal cavity facing greater risk [11]. Visceral fat associates with triglyceride-rich lipoproteins, fatty acids and inflammation, independently of BMI or subcutaneous fat [11].
Visceral fat drains to the liver via the portal circulation and exposes the liver to VF-released proinflammatory molecules and fatty acids, unlike subcutaneous fat [11]. This anatomical difference explains why visceral adiposity associates with metabolic profiles predictive of type 2 diabetes and myocardial infarction even in normal-weight individuals [11].
Pathological adipose tissue remodelling in postmenopausal women characterises itself through adipocyte hypertrophy, pericellular fibrosis and chronic inflammation, all contributing to insulin resistance [9]. Visceral fat appears more susceptible to obesity-driven inflammatory signals and serves as the biggest producer and secretor of IL-6 and TNF-α compared with subcutaneous fat [12]. The tissue enters a hyperinflammatory state and encourages insulin resistance, hypertriglyceridemia and continued chronic low-grade inflammatory responses [12].
The link to insulin resistance and inflammation
The connection between visceral fat accumulation and metabolic dysfunction operates through multiple pathways. Postmenopausal women showed higher plasma HbA1c and lower estimated insulin sensitivity compared with premenopausal women [9]. Increased HIF-1α and MCP-1 expression in VAT associated with decreased estimated insulin sensitivity even after correcting for VAT mass [9].
Menopause associates with increased CD163+ cell infiltration in VAT [9]. These cells play a role in tissue repair and matrix remodelling, yet their presence indicates ongoing inflammatory processes. The regression analyses revealed that associations between VAT adipocyte size, pericellular fibrosis and HIF-1α with estimated insulin sensitivity were stronger than the association between estimated insulin sensitivity and VAT mass itself [9].
Understanding inflammation and menopause becomes essential, as visceral adiposity in postmenopausal women increases risk for high blood pressure, unhealthy blood fats, sleep apnoea, heart disease, high blood sugar, diabetes, certain cancers, stroke, fatty liver and early death from any cause [9]. These metabolic aberrations are the foundations of metabolic syndrome and position belly fat as a central driver of age-related disease in women over 55.
Menopause and Blood Sugar Control
How oestrogen improves insulin sensitivity
Oestrogen supplementation improves glucose tolerance and reduces both fasting insulinemia levels and insulin resistance [9]. The hormone achieves this through direct action on the liver. It improves insulin sensitivity there and suppresses gluconeogenesis via the transcription factor Foxo1 [9]. Oestradiol reduces glucose levels by 21% in ovariectomised females and by 16% in males [9].
The mechanism involves increased phosphorylation of Akt and Foxo1. Oestradiol boosts these markers by 1.7-fold and 1.5-fold respectively [9]. Oestrogen receptor alpha (ERα) represents the major form of oestrogen receptors in the liver. Activation of ERα is required for oestradiol to suppress hepatic glucose production [9]. Oestradiol induces insulin receptor substrate 2 (Irs2) by 50% and suppresses glucose-6-phosphatase by 24% [9].
A meta-analysis of 17 randomised controlled trials including 15,350 participants receiving hormone therapy found that both oral and transdermal routes reduced insulin resistance in healthy postmenopausal women [9]. Oestrogen alone associated with a more prominent reduction compared with combination hormone therapy [9].
Why diabetes risk increases after menopause
Women after natural menopause had an age-adjusted odds ratio of 1.40 for diabetes compared with premenopausal women. Women after menopause by surgical or other causes had an odds ratio of 1.59 [13]. Postmenopausal nondiabetic women had an elevated odds ratio of 1.33 for prediabetes [13].
Women who began menopause before age 46 were 25% more likely to develop type 2 diabetes. This compares with women who had their final period between ages 46 and 55 [12]. Women who had their final period after age 55 faced a 12% increased risk [12]. Women with the shortest lifetime reproductive cycles (less than 30 years) were 37% more likely to develop diabetes than those with medium length reproductive cycles [12].
Postmenopausal status associated with an elevated odds ratio of 1.50 for dysglycemia even among women aged under 50 years [13]. The association of type 2 diabetes and postmenopausal status becomes attenuated after adjustments for hypertension and blood lipid measurements [13].
The thyroid connection in women over 55
Hypothyroidism affects women seven to 10 times more than men. Its rate increases with age [14]. The incidence of elevated thyroid-stimulating hormone (TSH) reaches about 17% in women over 70 years of age [14]. The risk for developing hypothyroidism is 1.4 per 1,000 per year in women aged 18 to 24 years. This rises to 6.7 per 1,000 per year in women aged 65 to 74 years and 14 per 1,000 per year in women aged 75 to 80 years [14].
Thyroid disorders occur 10 times more in women than in men [14]. Therefore, it is not unusual for midlife women going through perimenopause to also have a thyroid condition [14]. Hypothyroidism causes hypertension and cardiac insufficiency. It also causes adverse lipid profile, insulin resistance and endothelial dysfunction. These pose an increased risk for atherosclerosis, cardiovascular disease and type 2 diabetes [14].
Cortisol, stress and appetite changes
Fluctuating oestrogen and progesterone levels during menopause can lead to higher baseline cortisol levels or prolonged cortisol response to stress [11]. Cortisol raises blood sugar levels and affects the immune, digestive and reproductive systems [11]. High cortisol during menopause can raise blood pressure and blood sugar. This may lead to the development of type 2 diabetes [11].
Women in the late menopausal transition stage had cortisol levels of 53.4 ng/mg creatinine. Women in the early menopausal transition stage had 45.3 ng/mg creatinine [11]. Cortisol levels in women experiencing the menopausal transition and early postmenopause associated with oestrone, testosterone and follicle-stimulating hormone levels [11]. Changes in cortisol levels across the menopausal transition may be associated with increased risk of metabolic syndrome and later development of diabetes and heart disease [11].
Weight gain can increase as the body finds alternative ways to raise oestrogen production by storing fat around the stomach [11]. Chronic stress and elevated cortisol create a vicious cycle that affects menopause metabolism through multiple pathways.
The Muscle Loss Crisis That Compounds Everything
Why oestrogen matters for muscle maintenance
Muscle mass declines at a rate of 3% to 5% per decade starting at age 30 and becomes noticeable around age 60 [13]. The menopausal transition accelerates this decline substantially. Oestradiol maintains skeletal muscle through stimulation of satellite cell proliferation [9]. These satellite cells serve as muscle stem cells and handle muscle repair and regeneration after activity.
Research measuring satellite cells in women at the time of peri- and postmenopause found a 15% decrease in satellite cell numbers over just one year [13]. This rapid depletion compromises the muscle's capacity to repair itself following exercise or injury. Oestradiol also reduces skeletal muscle protein breakdown by influencing FOXO3 de-phosphorylation and MuRF1 content in early-postmenopausal women [15].
The hormone protects skeletal muscle from apoptosis and defends against loss of muscle mass when deficient [13]. Studies administering transdermal oestradiol for one week in early-postmenopausal women increased the ratio of nuclear to cytosolic oestrogen receptor alpha protein by 60% in skeletal muscle [15]. This genomic activation affects protein metabolism and muscle preservation directly.
Sarcopenia acceleration at the time of menopause
Cross-sectional studies demonstrate that lean or muscle mass is lower in postmenopausal women compared to premenopausal women [15]. The prevalence of sarcopenia increases substantially at the time of the menopausal transition: 7% in premenopausal women, 3% in early perimenopausal women, 30% in late perimenopausal women, 27% in early postmenopausal women, and 32% in late postmenopausal women [15].
Late perimenopausal women showed appendicular lean mass index 10% lower compared to early perimenopausal women [15]. Lean body mass decreased by 0.5% per year (a mean annual absolute loss of 0.2kg) whilst fat mass increased by 1.7% per year at the time of the menopausal transition [9]. Postmenopausal status associates with 2.99 times higher risk of presenting with sarcopenia [9].
The quadriceps muscles weaken first at the time of perimenopause around age 45 [9]. These muscles are rich in fast-twitch fibres sensitive to hormonal shifts. Without adequate oestrogen, these muscles shrink more quickly and store more fat inside the tissue [9].
How testosterone decline affects muscle
Testosterone contributes to muscle maintenance and growth in women through promotion of muscle protein synthesis [16]. Free testosterone levels decrease at the time of the first years after menopause and potentially play a role in accelerated muscle mass loss [9]. Women produce testosterone from both ovaries and adrenal glands. Production decreases by more than 50% after surgical menopause [17].
Declining testosterone affects muscle tone and strength [18]. The hormone maintains normal metabolic function and muscle and bone strength while contributing to overall energy levels [18][17]. Oestrogen, progesterone, and testosterone work together to maintain muscle tone and function [9].
Why preserving muscle is your top priority
Muscle tissue demands more energy even at rest compared to fat reserves [19]. People with reduced muscle mass face 2.3 times higher likelihood of experiencing falls and bone fractures [19]. Sarcopenia associates with increased likelihood of adverse outcomes including falls, fractures, physical disability and mortality [9].
Lower muscle mass affects insulin sensitivity because muscles take in a large bulk of insulin [13]. This positions muscle preservation as central to metabolic health after 55 and affects not only strength and independence but also blood sugar control and cardiovascular risk.
Medical and Supplement Approaches to Support Metabolism
HRT: benefits, risks and who should consider it
Hormone replacement therapy remains the most effective treatment to manage menopausal symptoms [12]. Body-identical hormones delivered through patches, gels or tablets provide oestrogen that matches the structure of hormones your body produces [20]. These regulated preparations differ from unregulated bio-identical HRT that some private clinics offer [20].
Research demonstrates HRT reduces diabetes risk in postmenopausal women [14]. A meta-analysis of 17 randomised controlled trials that included 15,350 participants found both oral and transdermal routes reduced insulin resistance by a lot in healthy postmenopausal women. Benefits appear strongest when therapy begins before age 60 or within 10 years of menopause [21].
HRT carries risks that vary by formulation, dose and individual health profile. Both oestrogen-only and combined HRT associate with increased venous thromboembolism risk [14]. Combined HRT shows higher breast cancer risk in multiple studies [14]. Stroke risk demonstrates mixed findings depending on timing and type [14]. HRT improves bone mineral density and reduces fracture risk in 9 of 10 analyses [14].
Women with breast cancer, ovarian cancer, uterine cancer, history of blood clots, stroke or cardiovascular disease should not use HRT [21]. Those who began menopause before age 45 may especially benefit from oestrogen therapy to reduce risks of osteoporosis, heart disease and dementia that come with prolonged oestrogen deficiency [21].
NAD precursors for energy production
NAD+ pools decline with normal ageing, obesity and hypertension [11]. Given NAD's central role in mitochondrial function and energy production, supplementation with precursors offers potential support for metabolic health after 55.
Research testing nicotinamide mononucleotide (NMN) on 25 postmenopausal women with prediabetes over 10 weeks found improvements in insulin sensitivity, insulin signalling and healthy muscle tissue changes [22]. The most marketed NAD+ precursors include nicotinamide (NAM), NMN and nicotinamide riboside (NR) [11].
NR demonstrates better uptake than NMN in skeletal muscle [11]. NR degrades in human plasma and NMN degrades in human plasma as well, which suggests low systemic stability when you take them orally [11]. The body converts them into circulating NAM and NAD+ that boost levels in liver, kidney and skeletal muscle when administered through IV [11].
Current dosage recommendations based on available research include 250-500mg per day for NR and 250-900mg per day for NMN [22]. Side effects appear rare and minor, including diarrhoea, nausea, rashes, hot flushes and leg cramps [22].
Key supplements: magnesium, vitamin D, omega-3
Magnesium plays a vital role in bone health, muscle function and nervous system regulation [13]. Research shows it reduces insomnia and stress while supporting bone density [13]. Magnesium glycinate provides better absorption with minimal gastrointestinal side effects at 300-400mg per day [13]. The mineral regulates melatonin, which decreases during perimenopause, whilst also helping with anxiety and hot flushes that affect sleep quality [13].
Vitamin D and calcium work together to maintain bone density and reduce fracture risk [13]. The recommended dosage sits at 1,000-1,200mg of calcium and 800-1,000 IU of vitamin D per day [13]. Vitamin D helps your body absorb calcium and supports immune function. It plays a role in mood regulation [13]. It also helps reduce menopausal symptoms such as anxiety, osteoporosis, genitourinary syndrome and cardiovascular disease [13].
Omega-3 fatty acids, EPA and DHA, provide anti-inflammatory properties and cardiovascular benefits [13]. They reduce depressive symptoms and support heart health while helping with joint pain [13]. The recommended intake ranges from 1,000-2,000mg of combined EPA and DHA per day [13][13]. Omega-3s support brain health by enhancing neurotransmitter function and improving mood, memory and mental clarity [13]. They also help lower triglycerides and reduce blood pressure while supporting healthy cholesterol levels [13].
Fish oil contains high levels of EPA and DHA that come from fatty fish like salmon and mackerel [13]. Krill oil offers higher bioavailability due to astaxanthin that occurs in it [13]. Algal oil provides a plant-based alternative that suits vegetarians and vegans [13].
Berberine and blood sugar support
Berberine activates AMP-activated protein kinase (AMPK), the same enzyme that exercise and fasting activate [9]. This activation tells cells to change from 'store fat' mode into 'burn energy' mode and supports healthy glucose levels, fat metabolism and mitochondrial function [9].
Studies show berberine improves insulin sensitivity and lowers fasting blood glucose and HbA1c levels. It regulates lipid metabolism and reduces triglycerides [9]. One study that examined women with PCOS taking 550mg of berberine twice per day for 60 days found lower inflammatory markers, triglycerides, testosterone, BMI and visceral fat [23]. Some research suggests berberine may be more effective for PCOS than Metformin and has fewer side effects [23].
Research reviews state the beneficial effects of berberine for metabolism and health 'suggest that this molecule could be an effective natural supplement to ensure a smooth peri- and postmenopausal transition' [23]. Berberine offers a researched solution that supports energy, blood sugar and fat metabolism for women who experience insulin resistance and metabolic changes during menopause [9].
When to work with your GP
Many women experience conflicting information about menopause treatment and remain unsure which steps to take [18]. Specialist menopause support provides adequate time with skilled professionals who listen to concerns and discuss available options [18].
Private menopause consultations offer 45-minute appointments to create personalised care plans [18]. Medical expertise proves necessary when you need to prescribe HRT, as choosing the right formulation requires understanding of body-identical hormones, combined or sequential preparations and localised treatments for specific symptoms [12].
Women should consult healthcare providers before starting supplement regimens, NAD+ precursors, berberine or therapeutic doses of vitamins [22]. Individual factors including health status, age, medical conditions, family history and genetics affect how your body responds to treatments [20]. Advanced hormone testing helps women make informed decisions about HRT by analysing hormone levels and metabolism to reduce potential risks [20].
Goldman Laboratories emphasises an evidence-based approach to menopause metabolism support and recognises that medical supervision will give treatments that match individual health profiles while monitoring for adverse effects.
The Menopause Metabolic Health Protocol
Protein-focused nutrition strategy
Postmenopausal women need 1.0 to 1.2 grammes of protein per kilogramme of body weight each day [17]. A 68kg woman needs 68-81 grammes per day. Research shows women lose 0.6% muscle mass each year after menopause starts [16]. Getting enough protein becomes critical to preserve muscle.
Distribute protein across meals rather than packing it all into dinner. Each meal should contain 20-25 grammes of protein [24]. Higher protein intake links to lower frailty risk and better physical function after menopause [16]. Focus on lean poultry, fish, eggs, Greek yoghurt, tofu, beans and lentils [17].
Resistance training basics
A 12-week resistance programme increased hip strength by 19%, flexibility by 21% and dynamic balance by 10% in menopausal women [25]. Resistance training improves insulin sensitivity by increasing skeletal muscle mass and glucose clearance from circulation [15]. Sessions should last 30-35 minutes and be performed twice weekly with progressive load increases [25][26].
Exercises using resistance bands, ancle weights, dumbbells and bodyweight movements work well [25]. The resistance load should progress from 50% of one-repetition maximum during weeks 1-4, to 60% during weeks 5-8 and 70% during weeks 9-12 [26].
HIIT for insulin sensitivity
High-intensity interval training works better than resistance training to improve cardiorespiratory fitness and reduce systolic blood pressure, cholesterol and fasting blood sugar [15]. HIIT alternates vigorous exercise (working up to 80% maximum heart rate) with recovery periods at 40-50% maximum heart rate [19].
Sessions involve 45 seconds of work followed by 15 seconds of rest, totalling 10-30 minutes [27]. HIIT increases stroke volume, strengthens mitochondria, improves fat-burning capacity and manages visceral fat accumulation during menopause [27].
Managing sleep disruption and hot flushes
Sleep disturbance affects up to 69% of midlife women [28]. Postmenopausal women face two to three times higher risk of sleep apnoea compared with premenopausal women [29]. Target 7.5-8.5 hours of quality sleep per night [29].
Wear breathable sleepwear made from cotton, linen or bamboo [14]. Avoid spicy foods, caffeine and alcohol close to bedtime [14]. Regular exercise helps menopausal women fall and stay asleep [29]. Magnesium supplementation at 300-400mg daily eases insomnia and reduces stress while supporting bone density [covered in previous section].
Supporting gut health and the estrobolome
The estrobolome has gut bacteria capable of metabolising circulating oestrogen [21]. Gut microbiome diversity decreases after menopause [30]. The gut microbiota regulates oestrogen by secreting β-glucuronidase and participating in oestrogen metabolism [30].
Supplementation with probiotic strains including Bifidobacterium longum and Lactobacillus plantarum combined with soy isoflavones eases lipid metabolism disorders during menopause [30]. Prebiotics like inulin increase beneficial bacteria, promote organic acid release and inhibit bone loss [30]. A healthy estrobolome minimises oestrogen reabsorption and maintains hormone balance [21].
Intermittent fasting: should you try it?
Time-restricted eating (16:8 protocol) combined with exercise produces greater fat mass reduction, improved glucose control and decreased insulin resistance compared to exercise alone [31]. Women following intermittent fasting with exercise showed major decreases in BMI, waist circumference and insulin levels after 12 weeks [31].
Intermittent fasting improves insulin sensitivity and reduces visceral fat in postmenopausal women [11]. But you must maintain enough protein intake during feeding periods to prevent muscle wasting [11]. Start with a 12-hour fasting window and extend to 16 hours over time [22]. Adherence works better with 5:2 protocols than alternate-day fasting [11]. Postmenopausal women may tolerate intermittent fasting better than premenopausal women due to stable hormone levels [22].
Common Questions About Menopause and Metabolism
Does menopause affect metabolism permanently?
Metabolic changes during menopause are not irreversible [32]. Oestrogen deficiency creates lasting hormonal shifts, but adopting specific lifestyle strategies reduces these effects and improves overall health [32]. Weight gain stabilises about two years after the final menstrual period [33]. The body adjusts to a new hormonal baseline, which makes sustained metabolic improvements possible through targeted interventions.
How much weight gain is normal during menopause?
Women aged between 45 and 55 gain around half a kilogramme per year on average [13]. Research shows weight gain continues at about 1.5 pounds each year through the 50s [10]. Some studies report average gains of 5-7 pounds over the whole menopause process [34], and others indicate up to 10kg by the time menopause completes [35]. The most pronounced weight accumulation occurs during perimenopause and the original few years after the final menstrual cycle [36].
Can you reverse menopause weight gain?
Regular physical activity combined with reduced calorie intake reverses menopause weight gain [13]. Exercise recommendations include 2.5 to 5 hours of moderate intensity activity or 1.25 to 2.5 hours of vigorous activity weekly, plus muscle-strengthening activities twice weekly [13]. A healthy diet prevents weight gain and improves energy levels [13]. Menopausal hormone therapy may help redistribute fat from the midsection to peripheral sites [36].
What foods boost metabolism after menopause?
The Mediterranean diet has been shown to lower cardiovascular disease risk, metabolic syndrome, osteoporosis, dementia and certain cancers [36]. This plant-forward diet limits sugar, sodium and processed carbohydrates while including whole foods rich in nutrients, fibre and antioxidants [36]. Protein intake of 20-30g per meal supports satiety and prevents muscle loss [9]. Omega-3 and monounsaturated fats reduce inflammation, support brain health and ease hot flushes [9].
Is HRT safe for metabolism?
Menopausal hormone therapy reduces chronic disease risk including heart disease and type 2 diabetes [13]. HRT may help reduce belly fat after menopause [13]. But formulation, dose and individual health profile determine safety [covered in previous section]. Transdermal oestradiol shows lower thrombosis risk compared with oral administration [23]. HRT prescribed before age 60 has a favourable benefit-risk profile [23].
How long does it take to see results?
A 12-week resistance programme shows measurable improvements in hip strength, flexibility and balance [covered in previous section]. Time-restricted eating combined with exercise produces decreases in BMI, waist circumference and insulin levels after 12 weeks [covered in previous section]. Goldman Laboratories emphasises consistent application of evidence-based protocols for optimal metabolic health outcomes.
Conclusion
Menopause metabolism changes create substantial challenges, but these changes are not permanent sentences to weight gain and declining health. The strategies outlined here provide evidence-based pathways to restore metabolic function through targeted nutrition, resistance training and appropriate supplementation.
Adequate protein intake combined with regular strength work and support for mitochondrial function addresses the mechanisms rather than symptoms alone. Women who implement these protocols see measurable improvements in body composition, insulin sensitivity and energy levels.
Goldman Laboratories emphasises that metabolic health after 55 requires action. The right approach transforms menopause from a metabolic crisis into a chance for renewed vitality and strength.
Key Takeaways
Understanding how menopause affects metabolism empowers women to take control of their health during this significant transition. Here are the essential insights for maintaining metabolic wellness after 55:
• Hormonal decline slows metabolism by 50-70 calories daily - oestrogen loss directly reduces mitochondrial function and energy expenditure, requiring dietary adjustments to prevent weight gain.
• Visceral belly fat increases 123% after menopause - fat storage shifts from hips and thighs to the abdomen, creating serious health risks including diabetes and heart disease.
• Muscle loss accelerates dramatically during menopause - women lose 0.6% muscle mass annually, with sarcopenia prevalence jumping from 7% to 30% during the transition.
• Resistance training twice weekly preserves muscle and metabolism - 12-week programmes increase hip strength by 19% and improve insulin sensitivity more effectively than cardio alone.
• Protein intake of 1.0-1.2g per kg body weight prevents muscle wasting - distribute 20-25g across each meal to maintain metabolic rate and physical function.
• HRT significantly reduces diabetes risk and supports fat redistribution - body-identical hormones improve insulin sensitivity and may help reduce dangerous visceral fat accumulation.
The key to successful metabolic health after menopause lies in addressing the root hormonal causes through targeted nutrition, strength training, and appropriate medical support rather than simply restricting calories.
FAQs
Q1. Can you restore your metabolism after menopause? Metabolic changes during menopause are not irreversible. Whilst oestrogen deficiency creates lasting hormonal shifts, adopting specific lifestyle strategies such as resistance training, adequate protein intake, and appropriate supplementation can mitigate these effects and improve overall metabolic health.
Q2. What's the most effective way to lose weight during menopause? Combining regular physical activity with reduced calorie intake is the most effective approach. This should include 2.5 to 5 hours of moderate intensity exercise weekly, plus muscle-strengthening activities twice per week. Resistance training proves particularly beneficial as it builds muscle mass, which helps burn more calories.
Q3. Why does metabolism slow down during the menopause transition? Oestrogen loss directly reduces mitochondrial function and energy expenditure by approximately 50-70 calories daily. This hormonal decline affects how efficiently your body produces energy at the cellular level, whilst also reducing spontaneous physical activity and accelerating muscle loss, all of which contribute to a slower metabolic rate.
Q4. When do women typically experience the most weight gain during menopause? The most pronounced weight accumulation occurs during perimenopause and the initial few years after the final menstrual cycle. Women typically gain around half a kilogramme per year during this period, with weight gain usually stabilising approximately two years after the final menstrual period.
Q5. What type of exercise best supports metabolism after menopause? Resistance training twice weekly proves most effective for preserving muscle mass and metabolism. A 12-week resistance programme can increase hip strength by 19% and improve insulin sensitivity. High-intensity interval training (HIIT) also provides excellent benefits for cardiorespiratory fitness and blood sugar control.
References
[1] - https://www.reproductivefacts.org/news-and-publications/fact-sheets-and-infographics/menopausal-transition-perimenopause-what-is-it/
[2] - https://www.ncbi.nlm.nih.gov/books/NBK507826/
[3] - https://health.ucdavis.edu/blog/cultivating-health/perimenopause-menopause-and-postmenopause-what-to-know-and-how-to-treat-the-symptoms-/2025/12
[4] - https://www.sciencedirect.com/science/article/pii/S0753332222011970
[5] - https://pmc.ncbi.nlm.nih.gov/articles/PMC3964739/
[6] - https://www.medherant.co.uk/news/what-is-the-role-of-testosterone-in-womens-health-and-menopause/
[7] - https://www.drlouisenewson.co.uk/knowledge/the-importance-of-testosterone-for-women
[8] - https://www.newsonhealth.co.uk/knowledge/what-are-the-benefits-of-testosterone-for-women-who-take-hrt
[9] - https://www.empowerlifestylemedicine.com/menopause/best-foods-to-support-weight-loss-during-menopause
[10] - https://www.mayoclinic.org/healthy-lifestyle/womens-health/in-depth/menopause-weight-gain/art-20046058
[11] - https://pmc.ncbi.nlm.nih.gov/articles/PMC12052274/
[12] - https://www.mayfieldclinic.co.uk/blog/private-menopause-support-tunbridge-wells-expert-gp-care
[13] - https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/menopause-and-weight-gain
[14] - https://themenopausecharity.org/information-and-support/what-can-help/good-sleep/managing-sleep-in-menopause/
[15] - https://link.springer.com/article/10.1186/s12944-023-01940-x
[16] - https://www.patientslikeme.com/blog/protein-intake-menopause
[17] - https://mcpress.mayoclinic.org/women-health/how-much-protein-do-you-really-need-after-menopause/
[18] - https://www.bupa.co.uk/health/payg/menopause-plan
[19] - https://www.hopkinsmedicine.org/health/wellness-and-prevention/staying-active-as-you-age/sports-exercise-tips-for-women-over-55
[20] - https://thehealthsuite.co.uk/treatments/menopause-clinic-in-leicester/
[21] - https://www.mariongluckclinic.com/blog/hormones-and-gut-health-the-estrobolome-and-hormone-balance.html
[22] - https://health.clevelandclinic.org/intermittent-fasting-for-women
[23] - https://thebms.org.uk/publications/consensus-statements/bms-whcs-2020-recommendations-on-hormone-replacement-therapy-in-menopausal-women/
[24] - https://www.mdpi.com/2673-9488/4/3/16
[25] - https://news.exeter.ac.uk/faculty-of-health-and-life-sciences/first-of-its-kind-study-shows-resistance-training-can-improve-physical-function-during-menopause/
[26] - https://www.mdpi.com/2072-6643/17/20/3274
[27] - https://konenkihealth.com/is-high-intensity-interval-training-good-for-menopause/
[28] - https://journals.lww.com/menopausejournal/fulltext/2024/08000/sleep_disturbance_associated_with_the_menopause.11.aspx
[29] - https://www.hopkinsmedicine.org/health/wellness-and-prevention/how-does-menopause-affect-my-sleep
[30] - https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2025.1562332/full
[31] - https://link.springer.com/article/10.1186/s12967-024-05738-y
[32] - https://www.menopausespecialists.com/post/how-menopause-affects-metabolism-and-7-ways-to-improve-it
[33] - https://www.webmd.com/menopause/menopause-weight-gain-and-exercise-tips
[34] - https://www.patientslikeme.com/blog/boost-metabolism-during-menopause-diet-nutrition
[35] - https://onlinedoctor.lloydspharmacy.com/uk/womens-health-advice/menopause-and-weight-gain
[36] - https://www.uchicagomedicine.org/forefront/womens-health-articles/2023/april/menopause-weight-gain-hormone-therapy